Pharmstandard International’s Argos Therapeutics, Inc. ARGS Stock Holding History

Pharmstandard International’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$26K	Hold	256,030	–	–	0.09%	7
2018 Q2	$42K	Hold	256,030	–	–	0.17%	6
2018 Q1	$230K	Hold	256,030	–	–	0.58%	6
2017 Q4	$15.4K	Hold	256,030	–	–	15.79%	3
2017 Q3	$919K	Hold	256,030	–	–	2.68%	5
2017 Q2	$1.86M	Hold	256,030	–	–	6.45%	4
2017 Q1	$2.31M	Hold	256,030	–	–	6.17%	4
2016 Q4	$27.4M	Buy	+256,030	New	+$24M	23.59%	2

Pharmstandard International's ARGS Position: Q3 2018 in Review

Pharmstandard International held its Argos Therapeutics, Inc. (ARGS) position steady in Q3 2018 at 826,153 shares worth $83K. The position accounts for 0.29% of the portfolio, ranked #6.

Pharmstandard International first reported a position in ARGS in Q4 2016 and has held it in 8 quarters since. The position peaked at $64.9M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARGS as of Q3 2018.

Pharmstandard International held 826,153 shares of Argos Therapeutics, Inc. worth $83K as of Q3 2018.
Pharmstandard International left its Argos Therapeutics, Inc. share count unchanged in Q3 2018.
Argos Therapeutics, Inc. made up 0.29% of Pharmstandard International's portfolio in Q3 2018, its #6 holding.
Pharmstandard International first reported a position in Argos Therapeutics, Inc. in Q4 2016 and has held it in 8 quarters since.
Pharmstandard International's Argos Therapeutics, Inc. position peaked at $64.9M in Q4 2016.
1 fund tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q3 2018.

Based on Pharmstandard International's 13F filing for Q3 2018, filed 15 Nov 2018.